“In silico targeting of CYP19A1 and PTPN1 by Nigellidine: A network-based exploration of its antidiabetic pathway interactions”, IJBB, vol. 63, no. 5, pp. 506–519, Apr. 2026, doi: 10.56042/ijbb.v63i5.22700.